1,001 results on '"Gudasheva, T. A."'
Search Results
2. Low Molecular Weight NGF Mimetic Enhances the Overall Plasma Antioxidant Capacity in Rats with Streptozotocin-Induced Diabetes
3. Influence of Bis-(2,3,4-Trimethoxyphenyl)Azaalkanes Central Atom Type on Their Cardiotropic Activity
4. Effect of a Low-Molecular-Weight NGF Mimetic on a Combined High-Carbohydrate Diet/Streptozotocin-Induced Model of Type 2 Diabetes
5. Antidiabetic Effect of a New Original NT-3 Dipeptide Mimetic
6. Pharmacogenetic Analysis of the Interaction of the Low-Molecular-Weight BDNF Mimetic Dipeptide GSB-106 with TRK Receptors
7. Design, Synthesis, and Study of Anxiolytic Activity of New Pyrrolo[1,2-a]Pyrazine-Containing TSPO Ligands
8. Evidence of Selective Interaction of Nerve Growth Factor Dipeptide Mimetic GK-2 with TrkA Receptor Using TrkA and TrkB Knockout HT-22 Cells
9. Neuroprotective Effect of the Neuropeptide Cycloprolylglycine Depends on AMPA- and TrkB-Receptor Activation
10. Analysis of the Role of PI3K/Akt Pathway in the Realization of the Normalizing Effect of Low-Molecular-Weight Mimetics of NGF and BDNF on Activity of Prooxidant and Antioxidant Systems in C57BL/6 Mice with Modeled Diabetes
11. Dipeptide Ligands of TSPO
12. Synthesis of N1-(2,3,4-trimethoxybenzyl)-N2-{2-[(2,3,4-trimethoxybenzyl)amino]ethyl}-1,2-ethanediamine Organic Salts and their Cardiotropic Activity
13. Neuroprotective and Neuroregenerative Properties of Dimeric Dipeptide Mimetics of Individual NGF and BDNF Loops Under Conditions of an Experimental Ischemic Stroke Model
14. The First Dipeptide Mimetic of Neurotrofin-3: Design and Pharmacological Properties
15. Comparative Study of the Mnemotropic Activity of Dimeric Dipeptide Mimetics of Individual NGF and BDNF Loops Using a New-Object Recognition Test in Rats
16. Low-Molecular-Weight Perorally Active Nerve Growth Factor Mimetic Reduces Manifestations of Diabetic Neuropathy in Wistar Rats
17. Substituted Glyproline GZK-111 Retains Antihypoxic and Anxiolytic Activity Upon Peroral Administration
18. Low-Molecular-Weight Mimetic of BDNF Loop 2 Reduces Ethanol Consumption in Female Rats
19. Psychotropic and Neuroreceptor Effects of Cyclopropylglycine Upon Intranasal Administration
20. Effect of a Low-Molecular-Weight NGF Mimetic on a Combined High-Carbohydrate Diet/Streptozotocin-Induced Model of Type 2 Diabetes
21. Influence of Bis-(2,3,4-Trimethoxyphenyl)Azaalkanes Central Atom Type on Their Cardiotropic Activity
22. Synthesis and Cardiotropic Activity of bis-(2,3,4-Trimethoxybenzyl)Alkanediamines
23. Dose-Dependent Effect of Nerve Growth Factor Mimetic GK-2 in a Wistar Rat Diabetes Model
24. Effects of Original Compounds GSB-106, GML-3, and GZK-111 in an Experimental Lipopolysaccharide-Induced Anhedonia Model
25. Experimental Evaluation of Anxiolytic and Analgesic Properties of a New Linear Methoxyphenyltriazaalkane Derivative with Cardiotropic Activity
26. Design and Synthesis of Dipeptide Nerve Growth Factor Loop 1 Mimetics and In Vitro Studies of their Neuroprotective and Differentiation-Inducing Activities
27. Synthesis of Aminoalkyl Dibenzofuranone Oxime Derivatives Possessing Anticonvulsant Activity
28. Peptide Mimetic of BDNF Loop 4 Blocks Behavioral Signs of Morphine Withdrawal Syndrome and Prevents the Increase in ΔFosB Level in the Striatum of Rats
29. Dimeric mimetic of BDNF loop 4 promotes survival of serum-deprived cell through TrkB-dependent apoptosis suppression
30. ANTIDIABETIC EFFECT OF A NEW ORIGINAL NT-3 DIPEPTIDE MIMETIC
31. The PI3K/Akt Cascade Is Involved in the Antidiabetic Effect of Compound GSB-214, a Low-Molecular-Weight BDNF Mimetic
32. Synthesis and Structure—Activity (Anxiolytic) Relationship Analysis of Leucyltryptophan Ligands of 18-KDA Translocator Protein
33. Dipeptide Mimetics of Different NGF and BDNF Loops Activate PLC-γ1
34. Developing the Optimal Synthetic Schem for the Potential Nootropic Drug GZK-111, N-Phenylacetylglycyl-L-Proline Ethyl Ester
35. Influence of Aromatic-Group Structure on Cardiotropic Activity of Alkoxyphenyltriazaalkanes
36. Effect of Neuropeptide Cyclo-L-Prolylglycine on Cell Proliferative Activity
37. Behavioral Effects of Dimeric Dipeptide BDNF Mimetic GSB-106 in a Rat Model of Depressive-Like State
38. Synthesis and In Vitro Neuroprotective Activity of Glycine Analogs of Gk-2 Dimeric Dipeptide Mimetic of Nerve Growth Factor 4th Loop
39. Cardioprotective Effects of Metalloproteinase Inhibitor 1-({4-[(4-Chlorobenzoyl)amino]phenyl}sulfonyl-L-Proline in Modeled Acute Myocardial Infarction
40. GK-2 Reduces Death of Cultured Granule Neurons in Cerebellum Induced by the Toxic Effects of Zinc Ions
41. Synthesis of Dibenzofuranone-Oxime Derivatives with Anticonvulsant, Antihypoxic, and Anti-Ischemic Activity
42. Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes
43. Synthesis and Cardiotropic Activity of 1-(Methoxybenzyl)-4-{2-[(Methoxybenzyl)-Amino]Ethyl}Piperazines
44. Design, synthesis, and anticonvulsant evaluation of 4-GABA-3-nitrocoumarines, 1-thiocoumarines, quinolone-2-ones, and their derivatives
45. Elimination Half-Life of Short Peptide Drugs in Humans Extrapolated From Animal Pharmacokinetic Pharmacokinetic Studies
46. Synthesis and Cardiotropic Activity of Cyclic Methoxyphenyltriazaalkanes
47. A Low Molecular Weight Nerve Growth Factor (NGF) Mimetic Given Per OS Increases the Survival of Pancreatic β-Cells in a Streptozotocin Model of Diabetes
48. Deficit of Neurotrophins in Experimental Diabetes – Correction with a Proline-Containing Dipeptide
49. Synthesis and In Vitro Neuroprotective Activity of Analogs with Various Spacer Lengths of a Dimeric Dipeptide Mimetic (GK-2) of Nerve Growth Factor
50. Synthesis and Cardiotropic Activity of Linear Methoxyphenyltriazaalkanes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.